Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New therapy shows promise for healing war wounds in rwanda

NCT ID NCT07621731

Symptom relief Sponsor: Alexandros Lordos, PhD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a type of group therapy called Resilience-Oriented Therapy (RoT) for adults in Rwanda who were struggling with mental health issues like trauma, depression, anxiety, or anger. 427 people took part, and the therapy was tailored to each person's main problem, such as managing emotions or behavior. The goal was to see if the therapy could help reduce symptoms and improve well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

427 people

The number who actually took part.

Started

Apr 2023

Finished

Sep 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult participant aged 18 years or older. * Living in or connected to a selected RoT-eligible cluster in one of the five study districts in Rwanda. * Screened through the wider societal-healing screening process and assigned to one of the RoT variant pathways based on presenting mental-health or socioemotional profile. * Able and willing to complete baseline assessment and, if allocated to immediate RoT, participate in group sessions. * Written informed consent obtained according to local ethics requirements. Exclusion Criteria: * Acute clinical risk, including suicidality or other indication requiring more intensive clinical or hospital referral as first-line response. * Primary needs better matched to another intervention pathway after staged screening, including family-level healing or community sociotherapy. * Unable to provide informed consent or safely participate in group sessions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aggression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Aggression anxiety anxiety disorder Depression depressive disorder post-traumatic stress disorder Psychological Trauma Psychological Well-Being substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aggression Anxiety Depression Mental health Psychological trauma Psychosocial functioning Stress disorders, post-traumatic Substance-related disorders

Contacts and locations

Locations

  • Community and Health-Centre Settings, Musanze District

    Ruhengeri, Northern Province, Rwanda

  • Community and Health-Centre Settings, Ngoma District

    Ngoma, Eastern Province, Rwanda

  • Community and Health-Centre Settings, Nyabihu District

    Nyabihu, Western Province, Rwanda

  • Community and Health-Centre Settings, Nyagatare District

    Nyagatare, Eastern Province, Rwanda

  • Community and Health-Centre Settings, Nyamagabe District

    Nyamagabe, Southern Province, Rwanda

More trials for these conditions

Other studies related to the condition(s) this trial covers.